The Montreal Cognitive Assessment (MoCA) is sensitive to head injury and cognitive impairment in a residential alcohol and other drug therapeutic community
Introduction
Therapeutic communities (TCs) are a form of residential rehabilitation for individuals experiencing chronic and severe alcohol and other drug (AOD) problems and may particularly suit clients with associated comorbidities and other complexities as they place an emphasis on fostering social support within the community of residents in order to promote treatment engagement and completion. Dropout from AOD treatment in general is estimated to be as high as 57% in inpatient settings (Darke, Campbell, & Popple, 2012a; Deane, Wootton, Hsu, & Kelly, 2012 ; Vergara-Moragues, Gonzalez-Saiz, Lozano, & Verdejo Garcia, 2013) . Importantly, length of stay in TCs has been shown to be related to neurocognitive capacity (Fals-Stewart & Lucente, 1994; Fals-Stewart & Schafer, 1992; Fernández-Serrano, Pérez-García, Perales, & Verdejo-García, 2010a ). An extensive systematic review reported that cognitive deficits were one of the most consistently reported risk factors for dropout from AOD treatment, alongside personality disorder, low treatment alliance, and younger age (Brorson, Ajo Arnevik, Rand-Hendriksen, & Duckert, 2013) .
It is likely that most residential substance misuse programs deliver treatments that work optimally in those who possess intact cognitive abilities; that cognitive impairment among residents may hinder treatment success requires further consideration. Components of residential AOD treatment often rely on capacities such as executive function (defined broadly as "those capacities that enable a person to engage successfully in independent, purposive, self-directed, and self-serving behavior"; Lezak, Howieson, Bigler, & Tranel, 2012, p. 37) and working memory (Fernández-Serrano et al., 2010b; Yücel & Lubman, 2007) , as clients are required to integrate new information, formulate goals, establish new behavioural strategies, and plan for the future in overcoming addiction.
However, most misused substances impair attention, learning and memory, visuospatial abilities, and executive functioning, with perhaps the most robust deficits across all substances evident in inhibitory control, working memory, and decision-making (Fernández-Serrano, Pérez-García, Río-Valle, & Verdejo-García, 2010b; Yücel & Lubman, 2007; Yücel, Lubman, Solowij, & Brewer, 2007) . Structural and functional brain changes may occur after substance misuse (Broyd, van Hell, Yücel, & Solowij, in press; Caplan, Epstein, Quinn, Stevens, & Stern, 2007; Ersche & Sahakian, 2007; Gonzalez, 2007; Gruber, Silveri, & Yurgelun-Todd, 2007; Lorenzetti, Solowij, & Yücel, in press; Oscar-Berman & Marinkovic, 2007; Scott et al., 2007) . Traumatic brain injury (TBI) is also highly prevalent in substance misuse populations, leading to significant complexities in the process of AOD treatment (Sacks et al., 2009; Solomon & Malloy, 1992; Walker, Cole, Logan, & Corrigan, 2007; West, 2011) .
Although cognitive dysfunction is common in AOD samples and increasingly recognised by staff, there is often insufficient time or resources to implement detailed neuropsychological assessments. Cognitive assessment may be instrumental in facilitating the detection of AOD clients with clinically significant cognitive impairment, irrespective of aetiology. Assessing clients' cognitive capacities can inform subsequent implementation of strategies aimed at improving treatment retention and outcomes.
In the AOD treatment environment a brief but valid and reliable measure is required.
This would provide an indication of potential cognitive dysfunction and alert staff to the possibility that further neuropsychological assessment and/or treatment modifications may be indicated. The Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) comprises 12 items that tap five key neuropsychological domains: executive function, working memory, short-term memory, language, and visuospatial ability. The MoCA takes 15 minutes to administer, is a free resource (Nasreddine, 2014) , and can be administered by staff without formal neuropsychological training. Initial studies have found evidence supporting the use of the MoCA in AOD treatment settings (Copersino et al., 2009; Copersino et al., 2012) .
The current study was exploratory in nature and sought to provide a naturalistic overview of a sample of Australian TC residents, with the MoCA administered as a brief screening measure to assess neuropsychological functioning. Performance on the MoCA was investigated in relation to demographic, substance use, psychological, and other variables related to impairments in cognition, including TBI.
Material and methods

Participants
The 
Procedure
After a group information session, interested participants provided written consent and were individually assessed in a quiet testing room. This was conducted within the TC facility for the AOD group, and at a University psychology clinic for the control group. The
MoCA was administered in approximately 15 minutes, adhering to the administration and scoring guidelines (Nasreddine, 2014) . Additional information (e.g., basic demographics, history of head injury, current and past substance use for controls) was obtained through a ten-minute semi-structured interview and the Kessler Psychological Distress Scale (K10; Kessler et al., 2002) was administered, as well as the Severity of Dependence Scale (SDS; Gossop et al., 1995) for the AOD group. Control participants received a $20 gift card as reimbursement for their time.
Measures
MoCA
The MoCA was used to assess neuropsychological functioning across its purported five domains (executive function, working memory, short-term memory, language and visuospatial ability). Executive function is assessed using trail-making, phonemic fluency, and verbal abstraction tasks. Working memory is assessed using sustained attention, serial subtraction, and digit span forwards/backwards tasks. Short-term memory is assessed through the delayed recall of five nouns. Language is assessed using naming (low familiarity animals), sentence repetition, and the phonemic fluency task. Visuospatial ability is assessed using clock-drawing and cube-copying tasks. The MoCA has displayed acceptable reliability in clinical groups (Bernstein, Lacritz, Barlow, Weiner, & DeFina, 2011; Freitas, Simões, Marôco, Alves, & Santana, 2012) . Outcome measures included total MoCA score and domain subscores.
Clinical variables
The SDS (Gossop, Best, Marsden, & Strang, 1997) and has demonstrated acceptable psychometric properties (George, Kinner, Bruno, Degenhardt, & Dunn, 2010; Hides et al., 2007; Sunderland, Mahoney, & Andrews, 2012) .
Relevant demographic and substance use data routinely collected by WHOs were accessed, following participants and the director of the service providing written consent.
Data analysis
All data were analysed using IBM Statistical Package for the Social Sciences (version 19; IBM Corp, 2010) . The primary goals of the analysis were to compare the performance of residents and controls on the MoCA and to explore variation in MoCA scores and potential predictors (e.g., primary substance of misuse, gender effects) within the AOD sample.
Shapiro-Wilk statistics and visual inspection of histograms and boxplots determined that total MoCA score, MoCA domain subscores, age, years of education, K10 and SDS scores were not normally distributed for both AOD and control groups. Consequently, nonparametric techniques were employed for most of the analyses. Nonparametric analysis of covariance was required for some analyses to enable covarying demographic characteristics that differed between groups. Quade's (1967) distribution-free procedure was used as a nonparametric alternative to analysis of covariance (see Olejnik & Algina, 1985) . This involved ranking the dependent variable and all covariates for all cases, ignoring the grouping variable. Following this, the linear regression of the ranked dependent variable on the ranked covariate measure was calculated and the unstandardised residuals saved, again ignoring the grouping factor. To calculate Quade's F statistic, a one-way analysis of variance using the residuals from the regression as the dependent variable and the grouping variable as the factor was performed.
Total MoCA score and cognitive domain subscores were the primary dependent variables for analysis. However, factor analyses of the MoCA have demonstrated that domains may be grouped differently (e.g., Duro, Simões, Ponciano, & Santana, 2010; Freitas et al., 2012) . Given the multi-process nature of neuropsychological tasks, whereby any single task may tap into a range of perceptual, cognitive and motor abilities, and the overlapping nature of the cognitive domains assessed by the MoCA (Freitas et al., 2012) , we created an additional score for analysis of executive function. This was of particular interest because executive dysfunction is especially common in substance misusing individuals (e.g., were not grouped or included in these comparisons due to insufficient sample sizes of these subgroups (see Results). Finally, AOD users hospitalised after a head injury were compared to those without serious head injuries.
Results
Preliminary analyses
MoCA data were available for 128 AOD residents and 37 controls. For some analyses, the AOD sample was reduced to 95 due to missing data (e.g. primary substance of misuse, n=16; SDS and K10 scores, n=33). Table 1 displays demographic, substance use, psychological, and cognitive functioning variables for the AOD group. AOD residents were in their mid-thirties on average and predominantly male. Alcohol was the primary substance of misuse for almost one-third of the sample, followed by heroin and amphetamine misuse, with these three substances accounting for approximately 80% of the entire AOD sample.
The mean K10 score indicated very high levels of psychological distress and the mean SDS score indicated high levels of psychological dependence on participants' primary substance of misuse, although the range extended to 0 in some cases, reflecting that some residents had progressed further in their treatment. The prevalence of head injuries was particularly high in the sample. Of the 67.2% who had either lost consciousness or sustained a concussion after a head injury, the mean number of times this had occurred was 4.98 (SD = 5.95). Half of the total sample had been hospitalised after sustaining a head injury. All control participants were screened to ensure that they had not been dependent on alcohol or other substances and/or received treatment for substance use disorder in the past.
No control participant currently used any substance (excluding alcohol and tobacco) on a regular basis (i.e., greater than once a month), with minimal prior experimentation with drugs, and 76% drank alcohol less than twice per week. The 24% of control participants who drank alcohol more than once per week were screened to ensure that their current drinking
was not occurring at a problematic level that caused clinically significant impairment or distress. Despite attempts to match sample characteristics, controls were significantly 
MoCA scores
Comparison of the AOD and control group determined a significant difference in total
MoCA score, F(1, 163) = 5.28, p = .023, the combined executive function/visuospatial subscore, F(1, 163) = 6.91, p = .009, and the visuospatial domain alone, z = -2.43, p = .015, with poorer performance in the AOD group (Table 2) . None of the other cognitive domain subscores differed between groups: short-term memory, F(1, 163) = .25, p = .62, working memory, F(1, 163) = .27, p = .60, and language, F(1, 163) = 1.04, p = .31. There was a trend toward poorer executive function in the AOD group, F(1, 163) = 3.01, p = .08. 
Gender effects
There were no significant differences between male and female AOD participants in age, years of education, or SDS scores (all p > .28). Females tended to have higher K10 scores (M = 31.25, SD = 7.89) than males (M = 28.21, SD = 7.60), t(93) = -1.82, p = .07.
MoCA outcomes for males vs. females were not significantly different (all p > .10) although females tended to score slightly higher than males (Mdn 3 vs. 2) on executive subscores, z = -1.68, p = .09.
Primary substance of misuse
There were significant differences between primary substance of misuse groups in age, F(2, 92) = 8.25, p = .001, but not years of education, H(2) = 4.15, p = .13, or SDS scores, H(2) = 1.59, p = .45; age was therefore included as a covariate in the analysis. There were no significant differences in total MoCA score, F(2, 92) = .04, p = . (Table 3 ). There was a marginally significant difference for working memory performance, F(2, 92) = 2.98, p = .056, with the poorest performance in the stimulants group.
K10 scores were significantly different across substance of misuse groups, F(2, 77) = 5.96, p = .004, being higher in the stimulant group relative to the opiate group (p = .022) and the alcohol group (p = .07), with no difference between alcohol and opiate groups (p = .69). 
Exploratory analyses
Psychological distress and substance dependence
There were significant negative correlations between K10 scores and total MoCA scores, r = -.22, p = .012, executive function/visuospatial abilities, r = -.21, p = .015, and language scores, r = -.20, p = .021, and a trend for working memory, r = -.16, p = .06, in the overall AOD sample. K10 and SDS scores were positively correlated, r = .20, p = .049, but SDS scores were not correlated with any MoCA scores (all p > .05), other than a trend toward a correlation with executive function, r = .18, p = .085. This pattern indicates that greater psychological distress (but not greater drug dependence) is associated with greater cognitive impairment.
Head injuries
Given that 50% of the AOD sample had been hospitalised for a head injury, the impact of head injuries on cognitive function were imperative to investigate further. There were no significant differences in age, z = -1.24, p = .22, education, z = -.94, p = .35, or K10 scores, t (93) Figure 1 displays standardised (out of 6) MoCA domain scores for AOD participants hospitalised for head injuries, non-hospitalised AOD participants and controls.
Analysis of sample without significant head injuries
After exclusion of those who had been hospitalised after a head injury, the primary analyses were repeated to compare only those AOD residents who had not sustained head injures requiring hospitalisation with controls ( Table 2 ). The AOD group in this reduced sample (n = 64) were significantly older than controls (Mdn = 34 vs. 25, respectively), z = -4.82, p = < .001, and less educated (Mdn = 10 vs. 12), z = -3.65, p = < .001. With age and education included as covariates, there were no significant differences in total MoCA score, or primary substance of misuse were found in this sample without head injuries.
Clinical significance of impairment
To investigate the clinical significance of impairment, total MoCA scores were recoded as a dichotomous variable to indicate either the presence or absence of cognitive impairment according to the cut-off score suggested by Copersino et al. (2009) as ≥ 26 reflecting no evidence of cognitive impairment. Within the overall AOD group, 43.8% met criteria for cognitive impairment. After removing those hospitalised for head injuries, 37.5% met criteria for impairment and this represented a significantly greater proportion than the 16.2% of controls meeting criteria for impairment, χ²(1, N = 101) = 5.09, p = .019. However, after removing a further 27 participants in the AOD sample who had sustained concussion or lost consciousness after a head injury but had not been hospitalised, the prevalence of impairment dropped to 29.7% and this did not represent a statistically significant difference when compared to the 16.2% of impaired controls (p = .13). Subsequently, it was deemed appropriate to examine the prevalence of impairment within the AOD group who had been hospitalised after a head injury. Of those who had been hospitalised (n = 64), only 50% met criteria for cognitive impairment, indicating that hospitalisation for head injuries alone may not predict cognitive impairment. There was no difference in the total number of head injuries (including those that did not require hospitalisation) sustained by those who met criteria for impairment (Mdn = 3) vs. those who did not (Mdn = 3), p = .67.
Discussion
This study used a brief screening tool, the MoCA, to provide an overview of cognitive functioning in residents of a substance misuse TC. The major findings were that 43.8% of the AOD group met criteria for cognitive impairment and head injuries were a significant determinant of this impairment. Within the AOD group, 50% had been hospitalised after a head injury and were more cognitively impaired than those who had not sustained head injuries requiring hospitalisation. Greater psychological distress in the AOD group was also associated with greater cognitive deficits.
Neuropsychological functioning
AOD residents overall scored significantly lower on the MoCA and showed greater deficits in executive function and visuospatial abilities than controls. No other cognitive domains differed between residents and controls. Within the AOD group, there were no gender effects other than a trend toward males displaying greater executive dysfunction than females and females tended to have higher levels of psychological distress than males. MoCA outcomes did not differ according to primary substance of misuse, other than stimulant users showing marginally poorer working memory ability and higher levels of psychological distress. The lack of observed differences in neuropsychological outcomes between substance of misuse groups may be explained by the prevalence of polysubstance use in clients undergoing residential AOD treatment; differences may not be detected between groups in which substance use has reached a level necessitating residential treatment. Generally, clients in residential AOD treatment have extensive histories of substance use with considerable variability between individuals. Another possible explanation is that differences do exist between substance of misuse groups in residential treatment but that the current study did not possess group sizes large enough to detect these differences.
Head injuries
Half of the AOD sample in the current study had been hospitalised after a head injury and were more cognitively impaired than those who had not, with lower total MoCA scores, and poorer executive/visuospatial and working memory abilities. When the hospitalised group were excluded from the analysis, there were no differences in any neuropsychological outcomes between AOD residents and controls, and no differences between primary substance of misuse groups, but females in this subset displayed poorer working memory performance than males.
In general, these findings are congruent with the literature suggesting that cognitive impairments exist in AOD populations (Caplan et al., 2007; Ersche & Sahakian, 2007; Fernández-Serrano et al., 2010b; Gonzalez, 2007; Gruber et al., 2007; Oscar-Berman & Marinković, 2007; Scott et al., 2007; Yücel & Lubman, 2007; Yücel et al., 2007) and may be detected by a brief cognitive impairment-screening tool (the MoCA). In assessing a residential AOD sample, arguably we accessed those most severely affected by their addiction, and also those with a high prevalence of head injuries requiring hospitalisation.
The level of cognitive impairment detected in this sample, as measured by the MoCA, was not severe and was largely associated with TBI, a factor that has not routinely been considered in previous studies and may account for a significant portion of the deficits observed in the literature.
Implications
This study showed that having sustained a TBI requiring hospitalisation accounted for the majority of cognitive impairment detected in the sample. There are two major implications: first, simply asking clients whether they have ever sustained a head injury requiring hospitalisation may be the most time-efficient way to informally gauge the possibility of cognitive deficits. Clients may be unable, however, to provide accurate accounts due to the high rate of TBIs occurring during intoxication that may remain undetected and receive no medical intervention. Whilst half of the AOD group in the current study had sustained a head injury requiring hospitalisation, 50% of this subgroup did not meet criteria for impairment based on the MoCA score threshold. As such, screening for head injuries alone without subsequent cognitive assessment may lead to inflated estimates of impairment. Furthermore, this type of screening would not capture approximately one third of the AOD sample that had never sustained head injuries and yet met criteria for cognitive impairment. Thus, the second implication is that cognitive deficits may also exist independently of head injuries in AOD samples and hence require screening in their own right.
These complex findings highlight the importance of brief cognitive screening as a standardised assessment procedure for all clients entering residential treatment. In this way, treatment planning may account for the presence of cognitive deficits. Further neuropsychological assessment may be recommended and modifications to treatment and/or targeted interventions may be implemented.
Regardless of the aetiology of cognitive impairment, cognitive screening has the potential to inform interventions aimed at alleviating these deficits. For example, adjunct interventions to remediate cognitive deficits together with better-tailored specific treatments may bolster residential services, reducing dropout rates and consequently improving treatment outcomes. Evidence suggests that the neuropsychological deficits associated with TBI can be alleviated through cognitive remediation interventions Manley & Maas, 2013; Tsaousides & Gordon, 2009) , and there is emerging evidence for the use of cognitive remediation programs in substance misuse populations as a way to improve treatment retention (Bates, Buckman, & Nguyen, 2013; Fals-Stewart & Lam, 2010; Rupp, Kemmler, Kurz, Hinterhuber, & Fleischhacker, 2012; Verdejo-García, 2011; Wexler, 2011) .
Further research aimed at developing and trialling cognitive remediation programs for AOD populations is required and providing these interventions within residential treatment services would be most ideal (e.g., Gonçalves et al., 2014) .
Limitations and future directions
There are several limitations of the current study. There were clear differences between the AOD group and controls (e.g., age, education, inferred socioeconomic status).
While some of these differences were accounted for statistically, future research would benefit from the inclusion of better-matched control groups. The exploration of primary substance of misuse groups resulted in small sample sizes with reduced statistical power for comparison; larger samples in future studies may reveal substance-specific impairment.
Another limitation of the current study is its failure to assess for psychiatric comorbidities, which are common in AOD populations and add substantial complexity to the process of treatment. The current study utilised the K10 as a measure of psychological distress and higher scores were associated with greater cognitive impairment. Future studies should include formal psychiatric diagnoses in order to examine their interaction with substance use disorders and head injuries in terms of cognitive outcomes. Additionally, the current study focused on hospitalisation and frequency of head injuries, but not their nature, severity or age of occurrence, which could be further examined in future studies. Also, despite the AOD sample being abstinent from AOD, there was no assessment of their duration of abstinence or length of stay in residential services prior to cognitive assessment; this, along with a more detailed substance use history (including age of onset and number of years of substance use) and objective measures of abstinence (e.g. urine testing in both AOD and control samples), could have provided further information regarding the nature and extent of the observed cognitive deficits. Finally, the potential lack of sensitivity of the MoCA to more specific cognitive deficits in AOD populations cannot be underestimated; the scores observed in this sample were not substantially below the cut-off indicative of impairment. Nevertheless, the
MoCA can serve as a cost-effective screening tool that would detect severe deficits in those most requiring further neurocognitive assessment.
Conclusion
The current study identified that the MoCA may be usefully applied in the AOD treatment setting as a brief screening tool. We showed in a naturalistic snapshot of clients in AOD residential treatment that cognitive impairment is common and may be related to the effects of head injuries, which are also highly prevalent. Cognitive abilities such as executive function and working memory are important for AOD residents to engage meaningfully in treatment and achieve successful outcomes. If these capacities are compromised, residents may be more likely to drop out from treatment and fail to recover from their addiction. The first step in rectifying this situation is to improve the assessment and detection of those who present with cognitive deficits. This will help to inform modifications to treatment and/or cognitive remediation interventions that may be beneficial in accommodating and potentially remediating impairments in cognition, increasing the likelihood of treatment engagement and retention, and hopefully leading to long-term recovery from addiction.
